Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-01-23
2008-08-05
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S408000
Reexamination Certificate
active
07407982
ABSTRACT:
The present invention relates to novel covalent oligo and polyalkylene glycol conjugates with synthetic inhibitors of trypsin-type serine proteases, in particular inhibitors of the hemocoagulation protease thrombin, synthetic intermediates stages required in their production and their use for producing active ingredients for the treatment or prophylaxis of thrombotic complications.
REFERENCES:
patent: 5583146 (1996-12-01), Kimball et al.
patent: 5798377 (1998-08-01), Lumma et al.
patent: 5914319 (1999-06-01), Schacht et al.
patent: 0658585 (1994-11-01), None
patent: WO91/08229 (1991-06-01), None
patent: WO98/32466 (1998-07-01), None
Zalipsky S., “Chemistry of polyethylene glycol conjugates with biologically active molecules,” Advanced Drug Delivery Reviews, 16 (1995) pp. 157-182.
Lorand, L., et al., “a double-headed Gly-Pro-Arg-Pro Ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of γ chains by factor XIIIa,” Proceedings of the National Academy of Sciences of the United States, Jan. 1998, vol. 95, pp. 537-541.
Steinmetzer, T., et al., “New Thrombin Inhibitors Based on D-Cha-Pro-Derivatives,” Journal of Enzyme Inhibition, vol. 14, 1999, pp. 203-216.
Poschel, K., et al., “Parmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure,” Kidney International, vol. 58, 2000, pp. 2478-2484.
Boyer, J.R., et al., “Solubilisation of FerricytachromeCin Methanol Using a Crown Ether Absorption, Circular Dichroism and EPR Spectral Properties,” Biochemical and Biophysical Research Communications, vol. 127, No. 3, 1985, pp. 828-835.
Nowak Götz
Steinmetzer Torsten
Chung Susannah
HaemoSys GmbH
Kagan Binder PLLC
Shameem Golam M. M.
LandOfFree
Oligo or polyalkylene glycol-coupled thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligo or polyalkylene glycol-coupled thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligo or polyalkylene glycol-coupled thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4009579